e frontiers of womens cardiovascular research: ... Ending cardiac death in women through early detection ... Advancing new treatments for microvascular coronary dysfunction a... Identifying gender-specific genes and proteins that increase or re... Conducting clinical trials of promising new drugs for women ...
Date:4/16/2008
e frontiers of womens cardiovascular research:
- Ending cardiac death in women through early detection
- Advancing new treatments for microvascular coronary dysfunction, an often deadly disorder primarily affecting women
- Identifying gender-specific genes and proteins that increase or reduce the risk of heart disease in women
- Conducting clinical trials of promising new drugs for women
- Understanding how to harness nutrition, exercise, and stress management to reduce heart disease in women
Even physicians do not fully appreciate the degree to which women are at risk for heart disease. Most are insufficiently aware that a woman having a heart attack is 20 percent more likely to die from it than a man. Dr. Bairey Merz urges that It must become a top priority on the national medical agenda to make testing, diagnosis and treatments more relevant to female physiology. We are thrilled Ms. Streisand has chosen to make womens heart health a priority of her philanthropic giving. She goes on to explain: As an endowment, funding for the dissemination of education -- both among women and within the medical community -- and research into relevant testing and treatments can continue, not just for the immediate future, but for generations to come.
'/>"/>
Page: 1 2 Related medicine news :1.
John Hancocks EZ Route Post-Enrollment Education Program Wins 2008 Insight Award for Customer Advocacy in Financial Services2.
Nations Vending Industry Unveils New Health Oriented Vending Program:3.
Video: National Association of School Nurses Launches Educational Program to Address Surge of Prescription Drug Abuse by Americas Youth4.
Brandes Proposes 130 yen per Share Dividend and 10 Million Share Buyback Program for Ono Pharmaceutical Annual Meeting5.
Draft National Toxicology Program Report Supports Safety of Bisphenol A6.
Palmetto GBA Ranked Among Nations Best for Ethics, Compliance Programs7.
Precyse Solutions Launches Clinical Documentation Improvement Program to Assist Hospitals in Accelerating Revenues8.
Intronis Technologies eSureIT Partner Program Certified Gold By CMP Channels VARBusiness9.
At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)10.
McCarty Cancer Foundation Awards $50,000 Grant for Myeloma Research Program at Karmanos Cancer Institute11.
New Montefiore Program Targets Elder Abuse and Neglect